Society for Clinical Vascular Surgery
November 16, 2006

Viabahn-Assisted Subintimal Recanalization (VASIR) of Superficial Femoral Artery Occlusions

Back to Annual Meeting
Back to Program
Michael J. Verta, MD, Joseph R. Schneider, MD, Phd, Marc Alonzo, MD, David Hahn, MD.
Evanston Northwestern Healthcare, Evanston, IL, USA.

Objective: To evaluate VASIR in long recanalizations of the superficial femoral artery (SFA).
Materials: Twenty three patients (11 males, 12 females), mean age 70.1+10.9 years, were studied. Comorbidities were hypertension (20/23), coronary disease (14/23), and diabetes (11/23). Presenting symptoms were disabling claudication (10/23), rest pain (6/23), and tissue loss (7/23). Lesions were angiographically severe (TASC D 16/23, TASC C 5/23, TASC B 2/23); 4/23 had no continuous run-off vessels.
Methods: The SFA was recanalized percutaneously with standard subintimal techniques, then repaved with Viabahn stent grafts. Patients were followed with ABIs and duplex imaging at 1 month, then every 3 months.
Results: Technical success was achieved in 23/23 without complications. Mean pre-procedural ABI of 0.43+0.16 rose to 0.86+0.22 post-procedure. 13/23 patients developed palpable foot pulses. Median follow-up is 6 months (range 1-10 months).
Eight recanalizations failed from 1 day to 8 months post-procedure. Five were successfully rescued, two required urgent bypass, and one required amputation. Thus primary patency is only 65% but secondary patency is 87%.
There was no correlation between failure and symptoms, lesion severity, or run-off status, but in 4/8 failures, where stents went from adductor canal to just short of the SFA origin, stenosis occurred at the ends of the stent-grafts, suggesting deformational forces from knee flexion may play an important role.
Conclusion: VASIR shows considerable promise as a primary treatment for SFA occlusions, with diligent follow-up and aggressive re-intervention. Until failure mechanisms are better understood, it should not be routinely substituted for vein bypass in suitable patients.


Back to Annual Meeting
Back to Program